(a) Specifications.
The drug contains 1 or 1.5 milligrams of oxymorphone hydrochloride per milliliter of aqueous solution containing 0.8 percent sodium chloride.
(b) Sponsor.
See No. 060951 in § 510.600(c) of this chapter.
(c) Conditions of use.
(1)
The drug is a narcotic analgesic, preanesthetic, anesthetic, and substitute anesthetic adjuvant for intramuscular, subcutaneous or intravenous administration to cats and dogs as follows:
Dogs |
2 to 5 |
0.75 |
|
5 to 15 |
0.75-1.5 |
|
15 to 30 |
1.5-2.5 |
|
30 to 60 |
2.5-4.0 |
|
Over 60 |
4.0 |
Cats |
Small |
0.4-0.75 |
|
Large |
0.75-1.5 |
(2)
Do not mix with a barbiturate in the same syringe to preclude precipitation.
(3)
It tends to depress respiration. Naloxone hydrochloride and other narcotic antagonists are used to counter over-dosing.
(4)
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Code of Federal Regulations
[40 FR 13858, Mar. 27, 1975, as amended at 63 FR 7701, Feb. 17, 1998]